Sign in

CIK 0001781174

  • Emerging growth company

Acrivon Therapeutics, Inc.

Sign in to watch
Ticker
ACRV
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
825125532
Phone
+1 617-207-8979
Business address
480 ARSENAL WAY, SUITE 100, WATERTOWN, MA, 02472
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$37,028
in 8 filings

Net −$37,028. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-08-04 Levy Adam D. Chief Financial Officer Sale −1,142 $1.57 $2K 66,008
2026-05-18 Levy Adam D. Chief Financial Officer Grant or award +46,167 67,150
2026-03-01 Levy Adam D. Chief Financial Officer Grant or award · Stock Option (Right to Buy) +132,925 132,925
2026-01-14 Levy Adam D. Chief Financial Officer Purchase +8,832 $1.70 $15K 20,983
2025-08-01 Levy Adam D. Chief Financial Officer Shares withheld for taxes −1,164 $1.26 $1K 12,151
2025-04-01 Levy Adam D. Chief Financial Officer Grant or award · Stock Option (Right to Buy) +35,209 35,209

Page 1 of 1 · 6 trades